跳至主要内容
临床试验/ITMCTR2023000040
ITMCTR2023000040已完成2 期

Effect of Lianhua Qingwen granules/capsules on patients infected with the novel coronavirus: a multicenter, retrospective cohort study

Jiujiang Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 100(—)
性别
All

入选标准

  • 1. Asymptomatic infections and mild confirmed cases of the new coronavirus in accordance with the Diagnosis and Treatment Protocol of the Novel Coronavirus Pneumonia (Trial Version 9) after etiological testing;
  • 2. Age = 18 years old, male or female.

排除标准

  • 1. The nucleic acid test is positive, and the patient is diagnosed as common type, severe type, or critical type;
  • 2. Patients were nucleic acid-negative.
  • 3. Patients were taking Chinese patent medicine such as Huashi Baidu Granules, Jinhua Qinggan Granules, Xuanfei Baidu Granules, and Chinese herbal decoctions such as Qinghua PiHui prescription, Fuzheng Huazhuo prescription, Puping Qinghua prescription at the same time.

研究者

相似试验

Effect of Lianhua Qingwen granules/capsules on... | 临床试验